Plasma Amyloid-β Levels and Prognosis in Incident Dementia Cases of the 3-City Study.: Plasma amyloid and prognosis in incident AD

Abstract : Studies of plasma amyloid-β (Aβ) levels as potential biomarkers for incident Alzheimer's disease (AD) have yielded contradictory results. We explored the associations between plasma Aβ40, Aβ42, and truncated Aβ levels, and prognosis of dementia in participants of the prospective 3-City Study. 120 aged individuals diagnosed with 2-year incident dementia were followed up for seven years. The associations between Aβ plasma levels and baseline cognitive score, cognitive decline, and death were examined. A higher level of baseline plasma Aβ was associated with worse cognitive status two years prior to incident dementia diagnosis. In incident AD patients, the association was only significant for Aβ40 and Aβn-42. In the fast cognitive decliners group, especially in AD cases, a higher level of 5 pg/ml of baseline Aβ42, Aβn-42, Aβn-42/Aβn-40, and Aβ42/Aβ40 ratios were associated with a lower risk of fast cognitive decline based on the Isaacs Set Test score. There was no association between peptide levels and mortality in demented subjects. When assayed at prodromal stage, plasma Aβ levels may be potentially useful markers of fast cognitive decline in individuals who subsequently become demented.
Liste complète des métadonnées

Littérature citée [18 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00777823
Contributeur : Dominique Villebrun <>
Soumis le : vendredi 18 janvier 2013 - 11:04:54
Dernière modification le : jeudi 26 avril 2018 - 01:04:52
Document(s) archivé(s) le : samedi 1 avril 2017 - 06:56:54

Fichiers

inserm-00777823_edited.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Audrey Gabelle, Florence Richard, Laure-Anne Gutierrez, Susanna Schraen, Fleur Delva, et al.. Plasma Amyloid-β Levels and Prognosis in Incident Dementia Cases of the 3-City Study.: Plasma amyloid and prognosis in incident AD. Journal of Alzheimer's Disease, IOS Press, 2013, 33 (2), pp.381-91. 〈10.3233/JAD-2012-121147〉. 〈inserm-00777823〉

Partager

Métriques

Consultations de la notice

1049

Téléchargements de fichiers

866